Bortezomib in the Treatment of Cancer

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 1, Iss. 3, 2006-11 ,pp. : 397-403

Bentham Science Publishers

Access to resources Recommend Favorite

Synergistic effects of cisplatin and proteasome inhibitor bortezomib on human bladder cancer cells

By        

Oncology Letters, Vol. 10, Iss. 1, 2015-01 ,pp. : 560-564

Spandidos Publications

Access to resources Recommend Favorite

The p53-independent induction of apoptosis in breast cancer cells in response to proteasome inhibitor bortezomib

By Yerlikaya Azmi  

Tumor Biology, Vol. 33, Iss. 5, 2012-10 ,pp. : 1385-1392

Springer Publishing Company

Access to resources Recommend Favorite

Proteasome inhibitor bortezomib (PS-341) enhances RANKL-induced MDA-MB-231 breast cancer cell migration

By                  

Molecular Medicine Reports, Vol. 5, Iss. 2, 2012-01 ,pp. : 580-584

Spandidos Publications

Access to resources Recommend Favorite

Effects of the proteasome inhibitor bortezomib alone and in combination with chemotherapy in the A549 non-small-cell lung cancer cell line

By Mortenson Melinda   Schlieman Michael   Virudachalam Subbulakshmi   Bold Richard  

Cancer Chemotherapy and Pharmacology, Vol. 54, Iss. 4, 2004-10 ,pp. : 343-353

Springer Publishing Company

Access to resources Recommend Favorite